Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials-Reference-Cited by-同舟云学术

Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials

Published:2018-12-11 Issue:22 Volume:320 Page:2344
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Stunnenberg Bas C.¹,Raaphorst Joost¹²,Groenewoud Hans M.³,Statland Jeffrey M.⁴,Griggs Robert C.⁵,Woertman Willem³,Stegeman Dick F.¹,Timmermans Janneke⁶,Trivedi Jaya⁷,Matthews Emma⁸,Saris Christiaan G. J.¹,Schouwenberg Bas J.⁹,Drost Gea¹⁰,van Engelen Baziel G. M.¹,van der Wilt Gert Jan³

Affiliation:

1. Department of Neurology, Donders Institute for Brain Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands

2. Department of Neurology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands

3. Department of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands

4. Department of Neurology, University of Kansas Medical Center, Kansas City

5. Department of Neurology, University of Rochester Medical Center, Rochester, New York

6. Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands

7. Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, Dallas, Texas

8. MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, United Kingdom

9. Department of Pharmacology–Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands

10. University of Groningen, Department of Neurology and Neurosurgery, University Medical Center Groningen, Groningen, the Netherlands

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference28 articles.

1. Rare diseases research: expanding collaborative translational research opportunities.;Groft;Chest,2013

2. Adopting orphan drugs—two dozen years of treating rare diseases.;Haffner;N Engl J Med,2006

3. Clinical trials in rare disease: challenges and opportunities.;Augustine;J Child Neurol,2013

4. Determining optimal therapy—randomized trials in individual patients.;Guyatt;N Engl J Med,1986

5. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.;Zucker;J Clin Epidemiol,1997

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N‐of‐1 trials in epilepsy: A systematic review and lessons paving the way forward;Epilepsia;2024-09-10

2. Measuring the individualization potential of treatment individualization rules: Application to rules built with a new parametric interaction model for parallel-group clinical trials;Statistical Methods in Medical Research;2024-08-06

3. The development of a set of key points to aid clinicians and researchers in designing and conducting n-of-1 trials;Trials;2024-07-11

4. Expert opinion on mexiletine treatment in adult patients with myotonic dystrophy;Archives of Cardiovascular Diseases;2024-06

5. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review;BMC Medical Research Methodology;2024-05-07